6th Philosophy of Medicine Roundtable Understanding Disease and Illness
August 11-12, 2015
University of Bristol
Keynote speakers: Rachel Cooper (Lancaster) and Trish Greenhalgh (Oxford).
We will endeavour to enable access to all. Please let the conference administrator, Ms Jess Farr-Cox (email@example.com) know if you have any access requirements.
For more information, full program, and to register:
Enquiries should be directed to the conference administrator, Jess Farr-Cox (firstname.lastname@example.org).
Scientific committee: Rachel Ankeny, Alexander Bird, Alex Broadbent, Havi Carel, Fred Gifford, Harold Kincaid, Miriam Solomon, Julian Reiss, Jeremy Simon, David Teira.
This roundtable is supported by the Wellcome Trust, as part of the Life of Breath project (www.lifeofbreath.org).
Conférences Duhem 2015
Duhem 2015 La SPS a le plaisir de vous convier aux prochaines conférences Duhem, organisées en partenariat avec l’Académie nationale de médecine.
Thème : philosophie de la médecine
Date : 10 juin 2015
Lieu : Académie nationale de médecine, 16 Rue Bonaparte, 75006 Paris, Salle des séances
Orateurs invités :
– Paul Thagard (philosophie)
– Joël Coste (histoire et épistémologie de la médecine)
– Laurence Zitvogel (médecine)
– Marina Cavazzana-Calvo (médecine)
Programme détaillé :
9:00 Assemblée générale de la SPS
9:30 : Accueil
9:40 : Allocution de la Présidente de la SPS
9:50 : Allocution de Raymond Ardaillou, Secrétaire perpétuel honoraire de l’Académie
10:00 : Laurence Zitvogel (Inserm U1015, Institut Gustave Roussy), “Immuno-Oncologie ou La révolution thérapeutique en cancérologie”
10:45 : Commentaire, par Thomas Pradeu
11:00 : Question
11h15 : Pause café
11:30 : Joël Coste (Université Paris Descartes, Ecole Pratique des Hautes Etudes) “Les maladies chroniques en médecine”
12:15 : Commentaire, par David Teira
12:30 : Questions
12:45-14:15 : Déjeuner
14:15 : Marina Cavazzana (INSERM) “Thérapie génique des maladies héréditaires
15:00 : Commentaire, par Marie Darrason
15:15 : Questions
15:30 : Pause café
15:45 : Paul Thagard (University of Waterloo) “Explaining Mental Illness”
16:30 : Commentaire, par Luc Faucher (en cas d’indisponibilité : M. Lemoine)
16:45 : Questions
17:00 : Conclusion
A conference on Bioethics and the Philosophy of Medicine is to be held in the University at Buffalo, NY, on July 30 – August 1, 2015 .
The conference is centered on four presentations by Christopher Boorse and Jerome Wakefield, in which each criticizes the other’s work. Full details are available here.
For more information, email: email@example.com
Evidence Live (www.evidencelive.org) is an international conference aimed at addressing and attempting to solve problems within EBM, and is also a forum for criticisms of EBM. Philosophers of medicine interested in attending (and participating in) this conference are welcome. Through the efforts of Jeremy Howick, the International Philosophy of Medicine Roundtable has become an associate member of the Evidence Life conference. This enables members of the International Philosophy of Medicine Roundtable to register for this rather expensive conference at special rates, opportunities available are:
- Individual full access at full rate– £365 (Saving £160) this offer closes 06/04/2015
- Individual full access Monday only – £195 (Saving £80)
Individual full access Tuesday only – £175 (Saving £75)
If you are interested in registering for this conference, and would like to know more please contact Ruth Davis(firstname.lastname@example.org) letting her know that you are a member of the International Philosophy of Medicine Roundtable.
Co-Sponsored by the British Society for the Philosophy of Science and the Centre for the Humanities and Health, King’s College London
20 June 2014, 9:00am – 5:15 pm, King’s College London
Luis Flores (King’s) and Jonathan Fuller (Toronto) – “The Risk GP Model: The Standard Approach to Prediction in Healthcare”
Alex Broadbent (Johannesburg) – “Is Stability a Stable Category in Medical Epistemology?”
Maël Lemoine (Tours) – “Prediction from Preclinical Studies. The Tragic Case of TGN1412”
Barbara Osimani (Camerino) – “Safety Signals and Causal Information in Pharmacology: Evidence for Harm Prediction from Phase 0 to 4”
Federica Russo (Ferrara) – “The Integration of Social and Biological Mechanisms for Healthcare Prediction and Intervention”
Elselijn Kingma (Southampton) – TBA
Jacob Stegenga (Utah) – “Measuring Effectiveness”
Jeremy Howick (Oxford) – “Using Grünbaum’s Definition of Placebos to Improve the Predictive Power of Placebo Controlled Trials”
About the Workshop
Predicting what will happen is a central concern in epidemiology, health policy, public health, and clinical practice. Predictions are made about prognosis, about the benefits and harms of interventions and other exposures, about populations, and about individuals. The theme of prediction is also of growing interest in the philosophy of medicine, and includes topics such as: measuring the effectiveness of interventions; extrapolating from clinical research studies; applying average results to individuals; the use of mechanisms, causal models or animal models to predict; probabilities and predictions. The principle aim of this workshop is to bring together scholars working on various projects on prediction in order to further develop this important theme in the philosophy of medicine.
Registration for the workshop is free but mandatory. Space will be limited. For questions or to register contact Jonathan Fuller (email@example.com).
Wednesday 20 November
All sessions: P&S Building, 16th Floor, Room 16-405, 630 W. 168th St.
|8:30-8:45||Registration and breakfast|
|8:45-9:00||Welcome (Jeremy Simon)|
|9:00-10:30||Session 1: Clinical Trials (Chair – Miriam Solomon)|
|Kirstin Borgerson||An Argument for Fewer Clinical Trials|
|Sean Valles||The “Lumping” vs. “Splitting” Problem in Studies of the Hispanic Paradox|
|Maya Goldenberg||The Double Standard of Care in Multinational Clinical Trials|
|10:45-12:15||Session 2: Evidence (Chair – Jonathan Fuller)|
|Chris Blunt||The Myth of the Hierarchy of Evidence|
|Jennifer Bulcock||The Status of Mechanistic Evidence in Evidence-Based Medicine|
|Leah McClimans||The Role of Measurement in Establishing Evidence-Based Medicine|
|1:30-2:45||Keynote Speaker: Rita Charon|
|3:00-5:00||Session 3: Facts, values and disease (Chair – Ramesh Prasad)|
|Susan Hawthorne||Getting Facts and Values Right in Clinical Science: Examples from the Bariatric Surgery Literature|
|Helena Drage||Making Sense of the Value of Health: Health as a Thick Concept|
|Hanna van Loo and Jan-Willem Romeijn||Comorbidity in Psychiatry: Fact or Artifact|
|Rachel Ankeny||Shifting Index Cases in Degenerative Neurological Disease: a Philosophical Analysis of Recent Research on Huntington’s Disease|
Thursday 21 November
AM sessions: Russ Berrie Building, 1st Floor, Lecture Hall 2, 1150 St. Nicholas Avenue
PM sessions: P&S Building, 16th Floor, Room 16-405, 630 W. 168th St.
|8:30-8:45||Registration and breakfast|
|8:45-10:15||Keynote speaker: Ross Upshur|
|10:15-11:45||Session 4: Medical explanation (Chair – Ashley Graham Kennedy)|
|Lauren Ross||Explanations and Explanatory Models in Biomedicine|
|Tobias Huber||Network Analysis and the Brain|
|Michael Cournoyea||Suffering Unknown and Unknowable: Medically Unexplained Physical Symptoms as a Challenge to Medical Explanations|
|1:15-3:15||Session 5: Measurement, prediction and progress (Chair – Jeremy Howick)|
|Erik Angner||Apgar Scores and Measurement in Philosophy and Medicine|
|Maël Lemoine||What Does it Take to Naturalize a Mental Disorder?|
|Nina Atanasova||Animal Predictions of Human Responses|
|William Goodwin||Revolution and Progress in Medicine|
|3:30-5:00||Session 6: Health (Chair – Alain Leplege)|
|Cristian Saborido, María González-Moreno and Juan Carlos Hernández||Bringing the Philosophy of Biology and the Philosophy of Medicine Closer Together: Natural Normativity and the Theoretical Definition Of Health And Disease|
|Antoine C. Dussault and Anne-Marie Gagné||An Account of Health as Homeostatic Maintenance of Design, and some Epistemological Remarks|
|Lydia du Bois||Doing Away with Pathology: The Role of Context in Naturalistic Theories of Health|
MS Deadline: March 14, 2014
The role of philosophy in discussions of clinical practice was once regarded by many as restricted to a very limited version of ‘medical ethics’. But in recent years there has been a resurgence of interest in the philosophy of medicine and health care as an intellectually serious and practically significant enterprise. Controversies about evidence, value, clinical knowledge, judgment, integrity and ethics have required practitioners and policy-makers to confront the epistemic and moral basis of practice, while philosophers have found in these debates ways to invigorate and reframe the investigation of long-standing philosophical problems, about the nature of reasoning, science, knowledge and practice, and the relationships between epistemology and ethics, morality and politics.
The Journal of Evaluation in Clinical Practice is an international health sciences journal (Impact Factor 1.52) that focuses on the evaluation and development of clinical practice in medicine, nursing and the allied health professions. It has a large and diverse readership including practitioners and academics from a vast range of areas, and a twenty-year tradition of publishing papers raising epistemological, metaphysical and ethical issues underlying clinical policy and practice. April 2010 saw the publication of the first thematic issue of the journal devoted entirely to philosophical issues, and May 2013 saw the publication of the fourth of these ‘philosophy thematics’. In the anniversary year of the journal, we are seeking contributions to a fifth thematic issue in philosophy. Papers are particularly welcome on the following themes:
1. Philosophy and clinical practice. Aside from ethics, what role, if any, does philosophy have at the bedside? Do discussions of ontology and metaphysics have any place in the education of practitioners? Recent arguments about ‘Values-based Medicine’ have raised questions about the ‘foundation’ of medicine as a practice but what, if anything, is sui generis to medicine? Is the proper role of applied philosophy to discover the foundations of clinical practice, or is this idea based on a misconception of the proper scope and limits of philosophical questioning?
2. The ‘particularist turn’ in thinking about health care. Recent attention given to personalised and person-centred medicine represents a shift in focus from acquiring statistically reliable knowledge of a general nature to an interest in the complex and potentially unique features of real cases. In bioethics, so-called moral particularists have forcefully challenged the dominance of traditional, principle-based normative theories, arguing that only the exercise of discernment on a case-by-case basis can do justice to the specific, morally relevant features of real cases. These developments are accompanied by a renewed interest in narrative explanation and casuistry – but does the focus on the particular represent a coherent and progressive development or a distraction from the need for universally applicable standards of efficient and effective health care?
However, we welcome papers that do not fit neatly into either of these themes, but represent excellent examples of the application of philosophy to questions of substantive import in medicine and healthcare.
Manuscripts can be submitted online at: http://mc.manuscriptcentral.com/jecp – please mark the submissions clearly with the words “Philosophy thematic issue”.
The deadline for submission of manuscripts is 1st March 2014. Original papers are usually no more than 5000 words in length, and detailed author guidelines are available at http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2753/homepage/ForAuthors.html
11 June 2013
Department of Philosophy, 9 Woodland Road, Bristol
We intend to commence at 10.00. The workshop will take place in the Philosophy Common Room, Ground Floor, 9 Woodland Road. The programme is not quite finalised and we may have an additional speaker.
Stephen Senn (Centre de Recherche Public de la Santé, Luxembourg) “Being a statistician means never having to say you’re certain”
David Papineau (Department of Philosophy, King’s College, London) “What kind of causes do randomized trials tell us about?”
George Davey-Smith (MRC Centre for Causal Analyses in Translational Epidemiology, Bristol) “Origins of ‘fair tests’ of treatment in the late 19th century: how and why”
John Worrall (Department of Philosophy, Logic and Scientific Method, London School of Economics) “Removing the ‘mask’: a clear-eyed view of the virtues of “blinding” in clinical trials”
Alexander Bird (Department of Philosophy, Bristol) “From Mill’s Method of Difference to randomization in the logic of comparative trials”
Symposium at the Brocher Foundation, Geneva, 4-5 July 2013
Speakers: Alex Broadbent, Nancy Cartwright, Michael Marmot, Alfredo Morabia, Justin Parkhurst, Anya Plutinski, Jacob Stegenga, and Sridhar Venkatapuram.
ABOUT THE SYMPOSIUM
Health care financing and provision is undergoing a crisis around the world. In Europe, the cost of medical care are increasing, along with levels of national spending on healthcare. Moreover the rate of increase exceeds the rate of regional economic growth. Something must be done, but it is far from clear what is the right political or social response. In much of the developing world, on the other hand, the situation is the reverse: increases in prosperity, particularly in the BRICS countries, have not been accompanied by significant healthcare investment; or else significant healthcare investment has benefited only a small portion of society. South Africa, for example, has some of the best medical care in the world, but it is not available to the majority of the population, and preventable morbidity and mortality remains shockingly high. And in North America, there are both high medical costs and highly unequal access, something which the present government has spent considerable political capital attempting to remedy. In short, there is very little apparent agreement on how a healthcare system should be organized in order to be effective, efficient, and equitable, despite a near-universal acceptance that health is both morally and economically important to individual and national wellbeing.
Against this backdrop, this symposium is convened to examine the philosophical underpinnings of effectiveness, efficiency and equity. Public and political debate about healthcare reform inevitably focuses on who should pay and who should provide. This workshop, however, seeks to address the prior question of what works: what healthcare measures are effective for improving population health, how we know they have been effective, and what evidence we need before confidently deploying them in a given sociopolitical setting. Indeed, much of the tumult surrounding health care reform can only be understood when health policy is seen to share important common elements with other public policies. It is not determined only by scientific evidence, nor must it answer only to that evidence. It is also variously influenced by legal rights, bureaucratic norms, political negotiations, and market mechanism, and it must balance these forces against the scientific evidence for effectiveness. In this workshop we focus on the way scientific evidence fits into this complex sociopolitical setting: how it can, how in fact it does, and how it ought to influence healthcare reform.
In particular, the symposium has the following goals:
- To understand the notions of effectiveness, efficiency and equity as they are and ought to be employed in healthcare reform. Especially, to identify the normative implications of the first two, and to clarify the third.
- To assess the use of systematic reviews to drive healthcare reform. Especially, to bring together the various criticisms of their use, to identify evidence (if any) for their effectiveness, and to arrive at a clear “best practice” recommendation for the use of evidence in healthcare reform.
- To highlight the challenges facing developing countries attempting healthcare reform. Especially, to identify novel ways in which social determinants of health and disease might be managed as part of healthcare reform, and to specify the evidence necessary for such measures.
To register, visit http://www.brocher.ch/en/events/evidence-in-healthcare-reform/